Journal article
Cardiovascular outcomes with antihypertensive therapy in type 2 diabetes: An analysis of intervention trials
G Jerums, S Panagiotopoulos, E Ekinci, RJ Macisaac
Journal of Human Hypertension | SPRINGERNATURE | Published : 2015
DOI: 10.1038/jhh.2014.117
Abstract
In studies of antihypertensive therapy, relative cardiovascular (CV) risk reduction is largely independent of attained systolic blood pressure (SBP). How this translates to absolute risk reduction (ARR) in diabetes is not clear. We have compared 5-year CV outcomes in 10 studies of intensive versus moderate or active versus placebo therapy in subjects with type 2 diabetes and attained SBP
Grants
Funding Acknowledgements
R. MacIsaac has received lecture fees and/or travel grants from Lilly. E. Ekinci has received travels grants from Sanofi and Lilly. The remaining authors declare no conflict of interest.